MedTrace Logo

Effectiveness of Continous Adjuvant Lidocaine on General Anaesthesia on Tumor Craniotomy Surgery

NCT06249113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-02-16

No results posted yet for this study

Summary

This study aims to investigate the effect of adjuvant continuous lidocaine in General Anesthesia on Depth of Anesthesia (qCON), Pain Response (qNOX), and Blood Sugar Levels in Elective Primary Tumor Craniotomy Surgery

Conditions

  • Surgery
  • Anesthesia; Functional
  • Haemodynamic Instability

Interventions

DRUG

NaCl 0.9%

NaCl 0.9% continous intravenous on tumor craniotomy surgery

DRUG

Adjuvant lidocaine continous

Adjuvant lidocaine continous intravenous on tumor craniotomy surgery

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Arief Cahyadi, Specialist · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-16
Primary Completion
2023-11-23
Completion
2024-01-10

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06249113 on ClinicalTrials.gov